Curaleaf Holdings Files 6-K, Opts for Form 40-F

Ticker: CURLF · Form: 6-K · Filed: 2024-10-08T00:00:00.000Z

Sentiment: neutral

Topics: reporting, sec-filing, legal

TL;DR

Curaleaf filed a 6-K, confirming they'll use Form 40-F for annual reports.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on October 8, 2024, reporting for the month of October 2024. The filing indicates that Curaleaf will file its annual reports under Form 40-F, not Form 20-F. The report was signed by Peter Clateman, Chief Legal Officer, on October 8, 2024.

Why It Matters

This filing clarifies Curaleaf's reporting obligations with the SEC, indicating their preference for Form 40-F for annual reports, which is common for Canadian companies.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming reporting form choice and is not indicative of new financial or operational risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report for the month of October 2024 and to indicate that Curaleaf Holdings, Inc. files its annual reports under cover of Form 40-F.

Which form does Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. uses Form 40-F for its annual reports, as indicated by the checkmark next to 'Form 40-F' and the absence of a checkmark next to 'Form 20-F'.

Who signed this Form 6-K filing on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed this Form 6-K filing on behalf of Curaleaf Holdings, Inc.

On what date was this Form 6-K filed?

This Form 6-K was filed on October 8, 2024.

What is the principal executive office address of Curaleaf Holdings, Inc. as listed in this filing?

The principal executive office address listed is 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

From the Filing

0001756770-24-000062.txt : 20241008 0001756770-24-000062.hdr.sgml : 20241008 20241008164600 ACCESSION NUMBER: 0001756770-24-000062 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20241007 FILED AS OF DATE: 20241008 DATE AS OF CHANGE: 20241008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 241360778 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover100724.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: October 8, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated October 7, 2024 EX-99.1 2 pressrelease100824.htm EX-99.1 Document Curaleaf to Report Third Quarter 2024 Financial and Operational Results STAMFORD, October 7, 2024 -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company") , a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2024 after market close on November 6, 2024. Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights. Event: Curaleaf Third Quarter 2024 Financial Earnings Conference Call Date: Wednesday, November 6, 2024 Time: 5:00 p.m. ET Live Call: +1-844-512-2926 (U.S.), +1-416-639-5883 (Canada) or +1-412-317-6300 (International) Passcode: 1873022 Webcast: https://ir.curaleaf.com/events For interested individuals unable to join the conference call, a dial-in replay of the call will be available until November 13, 2024, and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 4809848 About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find, The Hemp Company and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis co

View on Read The Filing